Genes & Diseases Journal

This review examines #CRISPRCas #GenomeEditing in ex vivo and in vivo therapies, emphasizing non‑clinical safety challenges and risk mitigation crucial for translating these technologies into safe clinical applications. @cgtcatapult.bsky.social Read: doi.org/10.1016/j.ge...